(Press-News.org) Barcelona, Spain: Drugs designed to target HER2-postive breast cancer could also benefit some patients with bile duct cancer, according to results of a patient trial to be presented on Thursday at the 36th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain. Bile duct cancer is rare, treatment options are limited, and the survival rates are low.
The trial also suggests that a wider group of breast cancer patients – those with HER2-mutated breast cancer – could be treated with these drugs.
In the trial, researchers used a combination of tucatinib and trastuzumab to treat patients with a variety of different tumours, all of which had signs of changes to a protein called human epidermal growth factor receptor 2 (HER2).
The research was presented by Dr Yoshiaki Nakamura from the National Cancer Center Hospital East, Kashiwa, Japan.
The phase II trial included 217 patients from Europe, the USA, Japan and South Korea with various different types of tumours that either had unusually high levels of HER2 expression or alterations in HER2. Despite previous treatment, all the patients had tumours that had spread within the body (metastatic cancer).
Patients on the trial received 21-day cycles of tucatinib tablets twice every day and trastuzumab intravenously once every three weeks. Tucatinib and trastuzumab are drugs that have been designed to stop cancer cells from growing by targeting HER2. Because these treatments specifically target cancer cells, they can have fewer side effects than traditional chemotherapy.
Overall, patients in the trial had a 22.2% objective response rate (ORR). This is the proportion of patients whose cancer shrank. However, among the 30 patients with bile duct cancer who were taking part in the trial, the ORR was 46.7%.
A combination of tucatinib, trastuzumab and chemotherapy drug capecitabine is already approved for patients who have metastatic breast cancer with high levels of HER2 expression (known as HER2-positive). In the new trial of tucatinib and trastuzumab without capecitabine, for patients with metastatic breast cancer with alterations in HER2 (known as HER2-mutated), the ORR was 41.9% (31 patients).
Side effects experienced by patients included diarrhoea, nausea and anaemia.
Dr Nakamura said: “This chemotherapy-free combination was shown to be safe and well-tolerated. Very few patients had to stop treatment due to side effects.
“The results of the study show variable effects across different tumour types. However, patients with HER2-positive metastatic bile duct cancer and HER2-mutated metastatic breast cancer experienced clinically relevant overall response rates.
“These results support inclusion of this drug combination in guidelines for patients with previously treated HER2-postive bile duct cancer. The results for the patients with metastatic breast cancer suggest that those with HER2-mutated tumours could also benefit from these HER2-targeted treatments.”
Several other trials are testing tucatinib in combination with various different drug treatments, including in HER2-positive breast and bowel cancers.
Dr Tim Greten, senior investigator at the Center for Cancer Research, National Cancer Institute, USA, is co-chair of the EORTC-NCI-AACR Symposium and was not involved in the research. He said: “Cancer trials often focus on a particular type of tumour, such as breast or bowel cancer. This trial was designed to focus on the molecular make-up of the tumour, regardless of where it is in the body. This means that researchers can include rare forms of the disease, such as bile duct cancer, that urgently need more treatment options.
“HER2 has been well-studied in breast cancer, but we are starting to see that it could be a useful target for treating other cancers. This study suggests that using two drugs that both target HER2 could prove beneficial for a wider group of breast cancer patients and for some patients with bile duct cancer. However, this is an early trial, and we need to see further research to confirm these results.”
END
Treatments used for HER2-positive breast cancers could help patients with rare gastrointestinal cancer
Trial of tucatinib and trastuzumab also showed benefits for HER2-mutated breast cancer
2024-10-23
ELSE PRESS RELEASES FROM THIS DATE:
Little-studied RNA might be key to regulating genetic disorders like epilepsy, autism
2024-10-23
Study focused on ‘Goldilocks Gene’ CHD2 that causes autism and epilepsy
Deletion of long non-coding RNA CHASERR produces too much CHD2 protein in the cell, leaving patients wheelchair-bound, nonverbal and with intellectual delays
Patient’s dad from study: ‘We intuitively understood this was a lot bigger than just Emma’
‘It is mind-boggling that we only know what 1% of the human genome does’
CHICAGO --- When a gene produces too much protein, it can have devastating consequences on brain development and function. ...
UB researchers show why cannabis policies should shift to a harm reduction, health promotion approach to safeguard public health
2024-10-23
BUFFALO, N.Y. — Millions of Americans use cannabis to treat a plethora of health conditions. They are rarely under a health care provider’s supervision and their access to quality information about the substances they are consuming and their potential risks is limited at best.
A paper published today in the American Journal of Public Health, the official journal of the American Public Health Association, by University at Buffalo researchers calls attention to this concerning and potentially dangerous situation, which they say is a result of a policy environment historically driven by politics, not science.
The paper explains why there needs to be a shift in cannabis ...
Live well, think well: Research shows healthy habits tied to brain health
2024-10-23
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, OCTOBER 23, 2024
MINNEAPOLIS – In middle-aged people, having risk factors like blood pressure, blood sugar and cholesterol that are not well-controlled combined with not following certain healthy habits including exercise, diet and sleep, are linked to a higher risk of stroke, dementia or depression later in life, according to a study published in the October 23, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. These results do not prove that not having healthy habits increases the risk of these conditions, ...
Could poor sleep in middle age speed up brain aging?
2024-10-23
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, OCTOBER 23, 2024
MINNEAPOLIS – People in early middle age who have poor sleep quality, including having difficulty falling or staying asleep, have more signs of poor brain health in late middle age, according to a study published in the October 23, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that poor sleep accelerates brain aging. It only shows an association between poor sleep quality and signs ...
Fossils unveil how southern Europe’s ecosystem changed through Glacial-Interglacial Stages
2024-10-23
Fossils from more than 600,000 years ago reveal how Southern Europe’s animal community shifted between warm and cold climate fluctuations, according to a study published October 23, 2024 in the open-access journal PLOS ONE by Beniamino Mecozzi from the Sapienza Università di Roma, Italy and colleagues.
The Notarchirico site has long been valued as a source of information on the Early-Middle Pleistocene, with fossils stretching from around 695 thousand to 614 thousand years ago. The authors of the present study examined mammalian fossils at the site and how they might ...
Your ability to balance on one leg may be a reliable indicator of neuromuscular aging, with men and women showing significant declines over the decades
2024-10-23
Your ability to balance on one leg may be a reliable indicator of neuromuscular aging, with men and women showing significant declines over the decades
###
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0310764
Article Title: Age-related changes in gait, balance, and strength parameters: A cross-sectional study
Author Countries: U.S., Taiwan
Funding: AR-K25AG068368 RJP-Robert and Arlene Kogod Professorship in Geriatric Medicine KRK-W. Hall Wendel, Jr. Musculoskeletal Professorship The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. END ...
Most young adults in the UK consider non-consensual condom removal during sex to be wrong and a violation of consent, with almost 9 in 10 seeing it as a form of sexual assault, per survey of 18-25-yea
2024-10-23
Most young adults in the UK consider non-consensual condom removal during sex to be wrong and a violation of consent, with almost 9 in 10 seeing it as a form of sexual assault, per survey of 18-25-year-olds
###
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0298561
Article Title: A UK survey of young people’s views on condom removal during sex
Author Countries: U.K.
Funding: The author(s) received no specific funding for this work. END ...
Under climate change scenarios, 30-44% more land in Ethiopia might become suitable for growing arabica coffee by 2080, although some cultivated areas might also become unsuitable, per modelling study
2024-10-23
Under climate change scenarios, 30-44% more land in Ethiopia might become suitable for growing arabica coffee by 2080, although some cultivated areas might also become unsuitable, per modelling study
###
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0310945
Article Title: Analysis of current and future bioclimatic suitability for C. arabica production in Ethiopia
Author Countries: Ethiopia
Funding: The author(s) received no specific funding for this work. END ...
Cockroaches and maggots might be able to turn an invasive seaweed into a high quality compost, finds a new experimental study which provides hope for the environment and the circular economy
2024-10-23
Cockroaches and maggots might be able to turn an invasive seaweed into a high quality compost, finds a new experimental study which provides hope for the environment and the circular economy
###
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0311483
Article Title: Invertebrate composting quality of the invasive alga Rugulopteryx okamurae, prospects for its bio-recycling, management and circular economy
Author Countries: Spain
Funding: All the financial support has been received by professor Jose Carlos García-Gómez and any funder have influence in the research. The details are: - JCGG (68/83 / 4081/0171) Organization of American ...
Implantable device may prevent death from opioid overdose
2024-10-23
The opioid epidemic claims more 70,000 lives each year in the U.S., and lifesaving interventions are urgently needed. Although naloxone, sold as an over-the-counter nasal spray or injectable, saves lives by quickly restoring normal breathing during an overdose, administrating the medication requires a knowledgeable bystander – limiting its lifesaving potential.
A team from Washington University School of Medicine in St. Louis and Northwestern University in Chicago has developed a device that may rescue people from overdose without bystander help. In animal studies, the researchers found that the implantable device detects an overdose, rapidly delivers naloxone ...
LAST 30 PRESS RELEASES:
Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)
A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets
New scan method unveils lung function secrets
Searching for hidden medieval stories from the island of the Sagas
Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model
Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label
Twelve questions to ask your doctor for better brain health in the new year
Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes
Study identifies genetic cause for yellow nail syndrome
New drug to prevent migraine may start working right away
Good news for people with MS: COVID-19 infection not tied to worsening symptoms
Department of Energy announces $179 million for Microelectronics Science Research Centers
Human-related activities continue to threaten global climate and productivity
Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued
Unraveling the power and influence of language
Gene editing tool reduces Alzheimer’s plaque precursor in mice
TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies
Twisted Edison: Bright, elliptically polarized incandescent light
Structural cell protein also directly regulates gene transcription
Breaking boundaries: Researchers isolate quantum coherence in classical light systems
Brain map clarifies neuronal connectivity behind motor function
Researchers find compromised indoor air in homes following Marshall Fire
Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality
Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology
'Glass fences' hinder Japanese female faculty in international research, study finds
Vector winds forecast by numerical weather prediction models still in need of optimization
New research identifies key cellular mechanism driving Alzheimer’s disease
Trends in buprenorphine dispensing among adolescents and young adults in the US
Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility
Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity
[Press-News.org] Treatments used for HER2-positive breast cancers could help patients with rare gastrointestinal cancerTrial of tucatinib and trastuzumab also showed benefits for HER2-mutated breast cancer